Gary Wysocki
Physician Assistant · Buffalo, NYNPI 1568413102
Payments from drug & device makers
Across 68 payments — averaging $16.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$180
- AstraZeneca$129
- Lilly USA, LLC$92
- Amgen$84
- Exact Sciences$75
- Phathom Pharmaceuticals, Inc.$68
- plus $522 from 17 others
What the payments were for
- Food & beverage$1,12398%
- Education$252%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 12 | $180 |
| AstraZeneca | 8 | $129 |
| Lilly USA, LLC | 6 | $92 |
| Amgen | 5 | $84 |
| Exact Sciences | 4 | $75 |
| Phathom Pharmaceuticals, Inc. | 3 | $68 |
| Novo Nordisk | 4 | $64 |
| Indivior Inc. | 3 | $59 |
| Pfizer | 3 | $48 |
| Sanofi-aventis U.S. LLC | 2 | $45 |
| E.r. Squibb & Sons, L.L.C. | 3 | $45 |
| Merck | 2 | $35 |
| Boehringer Ingelheim | 2 | $28 |
| Shield Therapeutics Inc | 2 | $27 |
| OPKO Pharmaceuticals, LLC | 1 | $25 |
| Gilead | 1 | $23 |
| AbbVie | 1 | $21 |
| Novartis | 1 | $19 |
| Paratek Pharmaceuticals, Inc. | 1 | $19 |
| Vertex | 1 | $18 |
| Cipher Pharmaceuticals US LLC | 1 | $16 |
| International Rehabilitative Sciences, Inc | 1 | $15 |
| Insulet Corporation | 1 | $14 |
How this compares
$1,148 in reported general payments places this provider in the 75th percentile of 11,358 physician assistant providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 59 | $79,197 |
| MounjaroTirzepatide | 48 | $51,777 |
| TrulicityDulaglutide | 49 | $50,078 |
| XareltoRivaroxaban | 43 | $45,051 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 42 | $38,099 |
| EliquisApixaban | 29 | $30,180 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 48 | $29,497 |
| FarxigaDapagliflozin Propanediol | 21 | $24,640 |
| Spiriva HandihalerTiotropium Bromide | 27 | $20,046 |
| JanuviaSitagliptin Phosphate | 13 | $14,089 |
| Spiriva RespimatTiotropium Bromide | 22 | $13,371 |
| TradjentaLinagliptin | 18 | $12,939 |
| Breo ElliptaFluticasone/Vilanterol | 21 | $9,200 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 254 | $8,692 |
| SynjardyEmpagliflozin/Metformin Hcl | 12 | $7,521 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Spiriva Respimat, Tradjenta, Synjardy | $28 | $113,028111 claims |
| Lilly USA, LLCMounjaro, Trulicity | $92 | $101,85697 claims |
| GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta | $180 | $76,796111 claims |
| PfizerEliquis | $48 | $30,18029 claims |
| AstraZenecaFarxiga, Symbicort | $129 | $28,69938 claims |
| MerckJanuvia | $35 | $14,08913 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 11,358 physician assistant providers in New York.
Other physician assistant in Buffalo
- Scott SpringerBuffalo$95K
- Henry YuBronx$1M
- Michael AsbachAmherst$962K
- Janelle BunceJamestown$565K
- Kristyl Cuenca-SiskoNew York$478K
- Melissa WhiteGarden City$320K
- Lawrence HermanHolbrook$315K
- Kaitlyn NelsonBrooklyn$289K
- Sari KatzGarden City$271K
- Julius NwosuBronx$256K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.